Marije L van der Lee
Overview
Explore the profile of Marije L van der Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schellekens M, Zwanenburg L, van der Lee M
Curr Oncol
. 2024 Jul;
31(7):4003-4014.
PMID: 39057169
Resilience is defined as the maintenance or relatively quick recovery of mental health during and after adversity. Rather than focusing on psychopathology and its causes, resilience research aims to understand...
2.
de Korte A, de Rooij B, Boll D, van Loon I, Vincent N, Hoedjes M, et al.
J Psychosom Obstet Gynaecol
. 2024 Apr;
45(1):2340465.
PMID: 38622864
Objectives: Lifestyle promotion during follow-up consultations may improve long-term health and quality of life in endometrial cancer patients. This study aimed to identify barriers and facilitators to improve and sustain...
3.
Zwanenburg L, van der Lee M, Koldenhof J, Suijkerbuijk K, Schellekens M
Support Care Cancer
. 2024 Mar;
32(4):222.
PMID: 38470541
Purpose: Despite improved survival for people with advanced cancer due to new medical treatments, a growing group of long-term responders (LTRs) has to learn to live with uncertainties that affect...
4.
Westendorp J, Geerse O, van der Lee M, Schoones J, Van Vliet M, Wit T, et al.
Psychooncology
. 2023 Nov;
32(12):1827-1838.
PMID: 37957777
Objective: Issues regarding clinician communication remain an important source of complaints within healthcare. This systematic review aims to determine cancer patients' and their family caregivers' views on which clinicians' communication...
5.
van Roozendaal A, Schellekens M, van Woezik R, van der Lee M
Psychooncology
. 2023 Oct;
32(12):1876-1884.
PMID: 37902175
Objective: Approximately 25% of cancer patients suffer from cancer-related fatigue (CRF) after cancer treatment. CRF is a multi-factorial condition affected by several interrelated protective and perpetuating factors. As most studies...
6.
Luigjes-Huizer Y, Helsper C, de Wit N, van der Lee M
Psychooncology
. 2023 Oct;
32(12):1839-1847.
PMID: 37850876
Objective: Fear of Cancer Recurrence (FCR) is highly prevalent among cancer survivors and leads to decreased quality of life and increased healthcare costs. We assessed the effectiveness of a guided...
7.
van de Graaf D, Mols F, Smeets T, Trompetter H, van der Lee M
J Cancer Surviv
. 2023 Sep;
19(1):295-305.
PMID: 37740129
Purpose: Patients with chronic painful chemotherapy-induced peripheral neuropathy (CIPN) may experience a negative impact of CIPN on daily life. They can use various coping (i.e., dealing with symptoms and resulting...
8.
van de Graaf D, Engelen V, de Boer A, Vreugdenhil G, Smeets T, van der Lee M, et al.
J Cancer Surviv
. 2023 May;
18(5):1630-1639.
PMID: 37221391
Purpose: A significant proportion of cancer patients suffer from chemotherapy-induced peripheral neuropathy (CIPN). This descriptive study aimed to examine patients' experience of CIPN symptoms, daily limitations, involvement of healthcare professionals,...
9.
de Vlaming I, Schellekens M, van der Lee M
Support Care Cancer
. 2023 May;
31(6):325.
PMID: 37154974
Purpose: With the limited availability of mental healthcare, it is of utmost importance to provide care that matches the needs of patients: short if possible, but also more intense when...
10.
van de Graaf D, Smeets T, van der Lee M, Trompetter H, Baars-Seebregts A, Borosund E, et al.
Acta Oncol
. 2023 Mar;
62(7):676-688.
PMID: 36939672
Background: Around 30% of cancer survivors suffer from chemotherapy-induced peripheral neuropathy (CIPN) ≥6 months after completion of chemotherapy, which comes with limitations in daily functioning and worsened quality of life(QoL)....